These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26236924)

  • 21. Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patients.
    Lin CC; Bair MJ; Chen CJ; Lee KH; Chen MJ; Liu CY; Chang CW; Hu KC; Liou TC; Lin SC; Wang HY; Chu CH; Shih SC; Wang TE
    Kaohsiung J Med Sci; 2016 Jan; 32(1):10-5. PubMed ID: 26853169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients with chronic hepatitis B: a prospective cohort study in China.
    Qi X; Wang JY; Mao RC; Zhang JM
    J Viral Hepat; 2015 Jan; 22(1):46-54. PubMed ID: 25402626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of entecavir switch therapy in chronic hepatitis B patients with incomplete virological response to telbivudine.
    Lo AO; Wong VW; Wong GL; Chan HY; Cheung CM; Chan HL
    Antivir Ther; 2013; 18(5):671-9. PubMed ID: 23462214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.
    Lee M; Oh S; Lee HJ; Yeum TS; Lee JH; Yu SJ; Kim HY; Yoon JH; Lee HS; Kim YJ
    J Viral Hepat; 2014 Dec; 21(12):873-81. PubMed ID: 24351112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy.
    Piratvisuth T; Komolmit P; Chan HL; Tanwandee T; Sukeepaisarnjaroen W; Pessoa MG; Fassio E; Ono SK; Bessone F; Daruich J; Zeuzem S; Manns M; Uddin A; Dong Y; Trylesinski A
    Drugs Context; 2016; 5():212294. PubMed ID: 27403192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial.
    An J; Lim YS; Kim GA; Han SB; Jeong W; Lee D; Shim JH; Lee HC; Lee YS
    BMC Gastroenterol; 2017 Jan; 17(1):15. PubMed ID: 28103819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result.
    Cai S; Yu T; Jiang Y; Zhang Y; Lv F; Peng J
    Clin Exp Med; 2016 Aug; 16(3):429-36. PubMed ID: 26164128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis.
    Wu X; Cai S; Li Z; Zheng C; Xue X; Zeng J; Peng J
    Virol J; 2016 Apr; 13():64. PubMed ID: 27062520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study.
    Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Chang KC; Yen YH; Lin MT; Hu TH
    PLoS One; 2016; 11(3):e0149761. PubMed ID: 26964034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Telbivudine Versus Other Nucleos(t)ide Analogs on HBeAg Seroconversion and Other Outcomes in Patients with Chronic Hepatitis B: A Network Meta-Analysis.
    Liang X; Fan R; Sun J; Shaikh J; Taneja A; Gupta S; Hamed K
    Adv Ther; 2016 Apr; 33(4):519-31. PubMed ID: 26921204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA.
    Kim DH; Choi JW; Seo JH; Cho YS; Won SY; Park BK; Jeon HH; Shin SY; Lee CK
    Yonsei Med J; 2017 May; 58(3):552-556. PubMed ID: 28332360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Law ST; Lee MK; Li KK; Mok CK
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):193-8. PubMed ID: 26587867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients.
    Ono A; Suzuki F; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Saitou S; Arase Y; Ikeda K; Kobayashi M; Watahiki S; Mineta R; Kumada H
    J Hepatol; 2012 Sep; 57(3):508-14. PubMed ID: 22659518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B.
    Lee S; Park JY; Song K; Kim DY; Kim BK; Kim SU; Ku HJ; Han KH; Ahn SH
    Gut Liver; 2015 Nov; 9(6):776-83. PubMed ID: 25963085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients.
    Lü W; Yang HH; Fan YM; Li T; Zhang LF; Mui C; Fan HW; Zhou BT; Liu ZY; Ng H; Liu XQ
    Chin Med J (Engl); 2013 Jun; 126(12):2333-6. PubMed ID: 23786949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.
    Lok AS; Trinh H; Carosi G; Akarca US; Gadano A; Habersetzer F; Sievert W; Wong D; Lovegren M; Cohen D; Llamoso C
    Gastroenterology; 2012 Sep; 143(3):619-628.e1. PubMed ID: 22643350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of adefovir dipivoxil or telbivudine monotherapy on renal function of patients with chronic hepatitis B].
    Li X; Zhong C; Yang S; Fan R; Peng J; Guo Y; Sun J; Hou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):826-9. PubMed ID: 22699063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis.
    Shen H; Ding F; Wang Z; Sun F; Yu Y; Zhou J; Xu W; Ni J; Wang J; Yang Y
    Cell Physiol Biochem; 2016; 40(1-2):370-378. PubMed ID: 27866195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ; Liu K; Ma YJ; Wang J; Chen EQ; Tang H
    J Viral Hepat; 2013 Apr; 20 Suppl 1():40-5. PubMed ID: 23458523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.